association (references)

References for: association

Full identifier: http://purl.org/np/RAL6CgExAulYiEjFfdIFVWQ8P0NQlGSVWLcf9Mbw60K8M#association

Nanopublication	Part	Subject	Predicate	Object	Published By	Published On
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#type type	http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement	Leoni Bücken	2021-07-03T12:55:22.169Z
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/2000/01/rdf-schema#label label	benlysta belimumab is indicated for the treatment of patients aged 5 years and older with active autoantibody positive systemic lupus erythematosus sle who are receiving standard therapy limitations of use the efficacy of benlysta has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus benlysta has not been studied in combination with other biologics or intravenous cyclophosphamide use of benlysta is not recommended in these situations benlysta is a b lymphocyte stimulator blys specific inhibitor indicated for the treatment of patients aged 5 years and older with active autoantibody positive systemic lupus erythematosus who are receiving standard therapy 1 limitations of use the efficacy of benlysta has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus benlysta has not been studied in combination with other biologics or intravenous cyclophosphamide use of benlysta is not recommended in these situations 1	Leoni Bücken	2021-07-03T12:55:22.169Z
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#object object	http://purl.obolibrary.org/obo/DOID_9074 DOID_9074	Leoni Bücken	2021-07-03T12:55:22.169Z
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate	https://w3id.org/biolink/vocab/treats treats	Leoni Bücken	2021-07-03T12:55:22.169Z
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject	https://identifiers.org/drugbank:DB08879 drugbank:DB08879	Leoni Bücken	2021-07-03T12:55:22.169Z
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/association_type association_type	https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation	Leoni Bücken	2021-07-03T12:55:22.169Z
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/provided_by provided_by	https://w3id.org/um/NeuroDKG NeuroDKG	Leoni Bücken	2021-07-03T12:55:22.169Z
http://purl.org/np/RAL6CgExAu... RAL6CgExAu	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/relation relation	https://schema.org/TreatmentIndication TreatmentIndication	Leoni Bücken	2021-07-03T12:55:22.169Z